Scout | Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)

The "Toward Translation of Nanotechnology Cancer Interventions" grant supports advanced pre-clinical research focused on developing nanotechnology-based cancer diagnostics and treatments. It aims to advance experimental nanomedicines that use nanoparticles or nano-devices to improve cancer treatment. The goal is to mature these technologies so they can proceed to further development stages, po…

Source

Agency: National Institutes of Health

Sub-agency: National Cancer Institute

Program: SBIR

Award

Award Ceiling: $475,000

Funding Amount: $475,000

Dates

Opportunity Released: November 23, 2021

Open for Submission: November 23, 2021

Submission Deadline: November 17, 2024

Application Window Closes: November 17, 2024

Keywords

nanotechnology

cancer

diagnostics

therapeutics

nanoparticles

nano-devices

nanomedicines

pre-clinical research

experimental therapeutics

translational development

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers